Conditions

Is B a Key to Autoimmune Therapy?: B Cell–targeted Therapies in Autoimmune Disease

Jennifer Anolik, MD, PhD | January 1, 2010

A perspective on B cell–targeted therapies in autoimmune disease

Kathy Holliman | December 1, 2009

Panel looks at decision making for treatment of three high-risk patients

Staff | December 1, 2009

Handpicked Reviews of Contemporary Literature

Stanley B. Cohen, MD | December 1, 2009

Complex coding and reimbursement rules can detract from patient care

Tuulikki Sokka, MD, PhD | December 1, 2009

The beliefs versus the data

Sue Pondrom | November 1, 2009

Science From Arthritis & Rheumatism

Michele Kaufman, PharmD, CGP, RPh | November 1, 2009

Information on News Approvals and Medication Safety

Daniel J. Clauw, MD | November 1, 2009

Exploring the peripheral and central elements of pain in FM

Daniel J. Clauw, MD | October 1, 2009

Fibromyalgia’s evolution from discrete entity to prototypical central pain syndrome

Gretchen Henkel | September 1, 2009

Prevention and management strategies continue to evolve